GPNMB and Parkinson disease: Similarly, Kia et al. recently found that eQTLs in brain tissue for CD38 and GPNMB based on a different eQTL dataset colocalize with PD risk loci33, strengthening the evidence for the encoded proteins as drug targets for PD.